| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |